Samsung Bioepis has confirmed that the company's biosimilar to Amgen's Enbrel, to be known as Eticovo, has been approved by the US FDA. This is the second US approval of an Enbrel biosimilar, with the first coming in August 2016 for Sandoz's Erelz

In the perennial search for blockbusters, US drugmaker Regeneron has acquired exclusive rights to access the technology and expertise of Calixar to conduct research and discovery of antibodies against an undisclosed target in various therapeutic f

The move comes just two months after Bayer, and darolutamide-partner Orion, revealed positive late-stage data for the non-steroidal androgen receptor inhibitor. Known as ARAMIS, the phase 3 program evaluated the safety and efficacy of darolutamide

GlaxoSmithKline has announced plans to spend $100 million to expand capacity at its Hamilton, Montana, site and boost production of vaccines, including Shingrix. The investment will create temporary construction and contracting jobs and a range of

Raising concerns over data collection and quality control, the US FDA has reportedly issued a 10-page Form 483 to Sun Pharma for its Dadra plant. As per published reports, the regulator found deficiencies relating to medicine quality, data collect

Samsung Bioepis has confirmed that the company's biosimilar to Amgen's Enbrel, to be known as Eticovo, has been approved by the US FDA. This is the second US approval of an Enbrel biosimilar, with the first coming in August 2016 for Sandoz's Erelz

Bloomberg is reporting that top U.S. trade negotiators have told biopharma companies that they may agree to China's demand that biologics receive only 8 years of market exclusivity as part of a trade deal, a blow to the biopharma industry. Alert r

A U.S. Patent for a " Magnetic Mixing System and Method" was awarded to Sani-Tech West on April 23rd , 2019. The present invention is a mixing system typically for use in a container for mixing its contents

Researchers at DOE's Lawrence Berkeley National Laboratory (Berkeley Lab) have 3D-printed an all-liquid device that, with the click of a button, can be repeatedly reconfigured on demand to serve a wide range of applications -- from making battery

Thursday, May 9th 2019

Flexibility and speed are key for the development of a new drug, from research to clinic and from clinic to market. Being able to produce a batch at the right time

Raising concerns over data collection and quality control, the US FDA has reportedly issued a 10-page Form 483 to Sun Pharma for its Dadra plant. As per published reports, the regulator found deficiencies relating to medicine quality, data collect

Gilead's experimental drug aimed at treating a type of fatty liver disease known as NASH failed to meet the main goal of a late-stage study this week, two months after it failed another trial. The current trial was testing two doses of selonsertib

GlaxoSmithKline has announced plans to spend $100 million to expand capacity at its Hamilton, Montana, site and boost production of vaccines, including Shingrix. The investment will create temporary construction and contracting jobs and a range of

A U.S. Patent for a " Chromatography Method"  w as awarded to GE on April 23rd , 2019. The present invention is a method for purification of immunoglobulin containing proteins or parts thereof, from conta

Start Codon, taking its name appropriately from a key messenger RNA (mRNA) sequence, will identify and recruit high potential companies from across the UK and beyond, drawing on the world-class resources of Cambridge's life sciences cluster to pro

Although they are considered the simplest of all life forms, even microorganisms sense their environment and are able to actively move within it. The ability of cells to target or avoid particular substances is called chemotaxis. Until now, scient

AbbVie has announced that the U.S. FDA has approved its Skyrizi drug as a treatment for plaque psoriasis at a time when its blockbuster psoriasis drug, Humira, faces patent pressures. The approval of Skyrizi, an injectable drug, is based on result

GlaxoSmithKline veteran Richard Saynor is coming home to Sandoz. Saynor has been named the new chief executive officer of the Novartis' subsidiary. For the past nine years, Saynor has been with GSK, most recently serving as senior vice president a

A U.S. Patent for a " Micro Titre Plate"  w as awarded to GE on April 23rd , 2019. The present invention is a micro titre plate comprising a number of wells disposed in a plurality of columns and rows, the

The US FDA this week announced it will hold a public meeting on May 16th, 2019 to evaluate ways to apply FDA's benefit-risk framework throughout the human drug lifecycle and best approaches to communicating FDA's benefit-risk assessment. After gat

Bluebird Bio has disclosed in a regulatory filing that it has a deal to sublease all of Sanofi's 267,000 sq. ft. at 50 Binney in Cambridge, MA starting in 2021. It will pay $99.95 per square foot, or nearly $26.7 million a year, to start, with ann

Start Codon, taking its name appropriately from a key messenger RNA (mRNA) sequence, will identify and recruit high potential companies from across the UK and beyond, drawing on the world-class resources of Cambridge's life sciences cluster to pro

This week Lilly announced a deal with Avidity Biosciences aimed at finding treatments for immunological diseases and other "select" indications by deploying the latter company's antibody oligonucleotide conjugate platform - which, as its name sugg

You had me worried for a second there, I thought for sure there was no way I was going to be able to get you where you wanted to go. Thankfully your reference to 'Boss' made me realize you had seen the 'Ross' single-use bag storage solution from t